COCP
What one share of Cocrystal Pharma holds
Pharmaceutical Preparations
Cocrystal Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.76 |
|---|---|
| Cash and investments | $0.16 |
| Book value | $0.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$3.30 | $0.00 | −$0.62 | — | $4.30 |
| 2017 | — | −$0.03 | $0.00 | −$0.29 | — | $4.34 |
| 2018 | — | −$1.75 | $0.00 | −$0.30 | — | $2.23 |
| 2019 | $0.21 | −$1.51 | $0.00 | −$0.05 | — | $0.73 |
| 2020 | $0.04 | −$0.17 | $0.00 | −$0.18 | — | $0.75 |
| 2021 | — | −$0.16 | $0.00 | −$0.14 | — | — |
| 2022 | — | −$4.77 | $0.01 | −$2.64 | — | $4.86 |
| 2023 | — | −$1.86 | $0.01 | −$1.53 | — | $2.59 |
| 2024 | — | −$1.72 | $0.00 | −$1.62 | — | $0.94 |
| 2025 | — | −$0.78 | $0.00 | −$0.73 | — | $0.46 |